Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple

Oleg Butovsky1, Gennady Landa, Gilad Kunis

  • 1Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.

Insights

High levels of interferon-gamma (IFN-γ) impair neural stem cell differentiation in rodents. However, interleukin-4 (IL-4) activated microglia promote oligodendrocyte regeneration and improve symptoms in demyelinating diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Stem Cell Biology

Background:

  • The role of activated microglia (MG) in demyelinating diseases like multiple sclerosis remains debated.
  • Interferon-gamma (IFN-γ), a cytokine linked to autoimmune conditions, influences microglial function.

Purpose of the Study:

  • To investigate the impact of IFN-γ on microglial function and oligodendrogenesis.
  • To explore the potential of IL-4 activated microglia in promoting central nervous system repair.

Main Methods:

  • Rodent models of demyelinating disease (EAE) were used.
  • Microglia were activated with varying levels of IFN-γ and IL-4.
  • The effect on neural stem/progenitor cell oligodendrogenesis was assessed.
  • IL-4 activated microglia were administered intrathecally.

Main Results:

  • High IFN-γ levels induced a microglial phenotype that inhibited oligodendrogenesis.
  • IL-4 reversed this inhibition, reduced TNF-α, and restored IGF-I production.
  • Intrathecal administration of IL-4 activated MG increased oligodendrogenesis and improved clinical signs in EAE rodents.
  • Newly formed oligodendrocytes were found near MG expressing MHC class II and IGF-I.

Conclusions:

  • Microglia activated by IL-4 can promote oligodendrogenesis from endogenous stem cells.
  • This suggests a novel therapeutic strategy for demyelinating diseases by modulating microglial function.

Related Concept Videos